The correlation between neuropathology levels and cognitive performance in centenarians

  • Meng Zhang
  • , Andrea B. Ganz
  • , Susan Rohde
  • , Linda Lorenz
  • , Annemieke J. M. Rozemuller
  • , Kimberley van Vliet
  • , Marieke Graat
  • , Sietske A. M. Sikkes
  • , Marcel J. T. Reinders
  • , Philip Scheltens
  • , Marc Hulsman
  • , Jeroen J. M. Hoozemans
  • , Henne Holstege

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

INTRODUCTION: Neuropathological substrates associated with neurodegeneration occur in brains of the oldest old. How does this affect cognitive performance?. METHODS: The 100-plus Study is an ongoing longitudinal cohort study of centenarians who self-report to be cognitively healthy; post mortem brain donation is optional. In 85 centenarian brains, we explored the correlations between the levels of 11 neuropathological substrates with ante mortem performance on 12 neuropsychological tests. RESULTS: Levels of neuropathological substrates varied: we observed levels up to Thal-amyloid beta phase 5, Braak-neurofibrillary tangle (NFT) stage V, Consortium to Establish a Registry for Alzheimer's Disease (CERAD)-neuritic plaque score 3, Thal-cerebral amyloid angiopathy stage 3, Tar-DNA binding protein 43 (TDP-43) stage 3, hippocampal sclerosis stage 1, Braak-Lewy bodies stage 6, atherosclerosis stage 3, cerebral infarcts stage 1, and cerebral atrophy stage 2. Granulovacuolar degeneration occurred in all centenarians. Some high performers had the highest neuropathology scores. DISCUSSION: Only Braak-NFT stage and limbic-predominant age-related TDP-43 encephalopathy (LATE) pathology associated significantly with performance across multiple cognitive domains. Of all cognitive tests, the clock-drawing test was particularly sensitive to levels of multiple neuropathologies.
Original languageEnglish
Pages (from-to)5036-5047
JournalAlzheimer's and Dementia
Volume19
Issue number11
DOIs
Publication statusPublished - 1 Nov 2023

Funding

The authors thank and acknowledge all participating centenarians and their family members and the team who visited the centenarians over the years: Chandeny, Debbie, Elizabeth, Esther, Ilse, Karlijn, Kimberley, Kimja, Linda, Linette, Marieke, Nina, Sanne, Sterre, and Tjitske for collecting the neuropsychological data. Finally, this work would not have been possible without the great collaboration we have enjoyed with the wonderful staff of the Netherlands Brain Bank. This work was supported by BrightFocus A2021031S and Stichting VUmc Fonds. H.H. and M.J.T.R. are recipients of ABOARD, a public‐private partnership receiving funding from ZonMW (73305095007) and Health∼Holland, Topsector Life Sciences & Health (PPP‐allowance; LSHM20106). H.H. was supported by the Hans und Ilse Breuer Stiftung (2020) and the HorstingStuit Foundation (2018). The authors thank and acknowledge all participating centenarians and their family members and the team who visited the centenarians over the years: Chandeny, Debbie, Elizabeth, Esther, Ilse, Karlijn, Kimberley, Kimja, Linda, Linette, Marieke, Nina, Sanne, Sterre, and Tjitske for collecting the neuropsychological data. Finally, this work would not have been possible without the great collaboration we have enjoyed with the wonderful staff of the Netherlands Brain Bank. This work was supported by BrightFocus A2021031S and Stichting VUmc Fonds. H.H. and M.J.T.R. are recipients of ABOARD, a public-private partnership receiving funding from ZonMW (73305095007) and Health∼Holland, Topsector Life Sciences & Health (PPP-allowance; LSHM20106). H.H. was supported by the Hans und Ilse Breuer Stiftung (2020) and the HorstingStuit Foundation (2018).

FundersFunder number
BrightFocus A2021031S
HorstingStuit Foundation
Nederlandse Hersenbank
ZonMwLSHM20106, 73305095007
Hans und Ilse Breuer-Stiftung

    Fingerprint

    Dive into the research topics of 'The correlation between neuropathology levels and cognitive performance in centenarians'. Together they form a unique fingerprint.

    Cite this